Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research focused on Lung cancer and Adenocarcinoma, with related work in Oncology, Chemotherapy, Immune system. Notable publications include 'Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?', 'Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis', and 'Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer'.
Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
872P Safety and efficacy of toripalimab combined with cetuximab in PD-L1 positive untreated recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase Ib/II study
Neoadjuvant nivolumab plus chemotherapy versus chemotherapy for resectable NSCLC: subpopulation analysis of Chinese patients in CheckMate 816
Vinculin phosphorylation impairs vascular endothelial junctions promoting atherosclerosis
Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis
Validation of a novel prognostic index: BMS-Score for patients with brain metastases of small cell lung cancer
Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?
<p>The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non–Small Cell Lung Cancer-Harboring EGFR Mutations</p>
Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations
Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases
Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China
Study of circulating IgG antibodies to BIRC5 and MYC in non‐small cell lung cancer
Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer
Circulating IgG antibody against FOXP3 may be a potential biomarker for lung cancer